마크로젠

In May 2024, Macrogen became the first non-medical biobank in South Korea to receive official approval from the Korea Disease Control and Prevention Agency (KDCA). ⠀ Macrogen Biobank securely collects and preserves human biospecimens (including blood, urine, tissue, and cells) to support cutting-edge research in drug development, genomics, and disease prediction modeling, shaping the future of medicine. ⠀ With 27 years of genetic data, we are integrating our biobank with GenTok, our app-based DNA testing platform, to drive innovation in precision medicine and digital health. ⠀ Over the next five years, Macrogen aims to transform the bioindustry by building a biobank of 10 million individuals. ⠀ Learn more about Macrogen Biobank: https://lnkd.in/g8r6tspM ⠀ #macrogen #gentok #genomics #Biobank

"Expanding into the Global Market is Key to the Success of Korean Bio Ventures“ Jeong-sun Seo, Chairman of 마크로젠, shared his insights in an interview with Chosun Ilbo, emphasizing the importance of entering overseas markets for the sustainable growth of the bio industry. ⠀ Founded as a laboratory startup in 1997, Macrogen became Korea’s first publicly listed bio venture in 2000. By offering sequencing services at an unprecedented price of just $5—one-fourth of competitors' rates—the company has emerged as a leader in the global market. ⠀ Recently, Macrogen has expanded beyond research-focused services to consumer-oriented solutions. Through its personalized genetic testing service, "GenTok," the company is helping more people take proactive steps in managing their health. ⠀ "We aim to showcase Korea’s medical technology capabilities to the world and pave the way for future players to enter the global market.“ ⠀ Read the full interview with Chairman Jeong-sun Seo in Chosun Ilbo at the link below. 👇 https://lnkd.in/gQbMnX8q ⠀ #macrogen #gentok #genomics #Interview

Over the past year, Macrogen has made significant strides—expanding its big data business, opening the Sejong campus, securing approval for a biobank, and earning an A-grade certification for its genetic testing lab. ⠀ As we enter 2025, the Year of the Snake, Macrogen is poised for even greater growth. In a rapidly evolving market, we will remain agile and adaptable, responding swiftly to changes while embracing the wisdom and resilience symbolized by the snake. With a forward-thinking approach, we are committed to strengthening our position as a global leader in digital healthcare. ⠀ We look forward to driving innovation and shaping the future of digital healthcare in 2025 and beyond! ⠀ #macrogen #gentok #genomics #NewYear2025

마크로젠 웨비나에 초대합니다! Single-cell multiplexing suggests innovative experimental directions ✨ 일시: 2025년 2월 12일(수) 오후 2시 ✨ 신청링크: https://lnkd.in/gJepvT-b 이번 웨비나에서는 10x Genomics의 공식 Service Provider인 '마크로젠'에서 제공하는 다양한 Single Cell Multiplexing 기술들과, 앞으로 도입 예정인 10x Genomics의 새로운 업데이트 내용을 소개합니다. 전문가와 함께하는 마크로젠 웨비나! 미리 신청하시고 놓치지 마세요 😀 *This webinar will be conducted in Korean only. #Singlecellmultiplexing #Singlecell #Rnasequencing #rna #10xGenomics

Looking back on an incredible 2024 ✨ ⠀ 2024 has been a year of tremendous growth and innovation for Macrogen. We achieved several significant milestones: ⠀ ✅ Opened the Macrogen Sejong Campus ✅ Selected as a partner for the National Integrated Bio Big Data Initiative ✅ Approved for Korea’s first non-medical biobank ✅ Signed an agreement with Samsung for DNA testing services ✅ Partnered with PacBio to advance Precision Health in Singapore ⠀ These accomplishments were made possible by the trust and support of our customers and partners, along with the dedication and hard work of our employees. ⠀ As we move into 2025, Macrogen remains committed to driving sustainable bio-innovation and building a better future for all. ⠀ #macrogen #2024wrapup #2024review #2024recap

Macrogen has been appointed as the lead organization of a four-company consortium for the National Integrated Bio Big Data Project, supported by the Ministry of Health and Welfare and the KDCA.🧬 ⠀ In collaboration with DNA Link, Theragen Bio, and CG invites, we are taking on the monumental task of producing and analyzing: ✔️ 𝟭𝟰𝟲,𝟬𝟬𝟬 𝘄𝗵𝗼𝗹𝗲 𝗴𝗲𝗻𝗼𝗺𝗲 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 (𝗪𝗚𝗦) 𝗱𝗮𝘁𝗮 𝘀𝗲𝘁𝘀 ✔️ 𝟮,𝟴𝟬𝟬 𝘁𝗿𝗮𝗻𝘀𝗰𝗿𝗶𝗽𝘁𝗼𝗺𝗶𝗰 (𝗺𝗥𝗡𝗔) 𝗱𝗮𝘁𝗮 𝘀𝗲𝘁𝘀 ⠀ This project marks the first step toward building comprehensive bio big data for 1 million Koreans by 2032, paving the way for advancements in drug development, disease prevention, and personalized medical services.🔬 ⠀ With our 27 years of proven expertise and research capabilities, Macrogen is committed to accelerating the advancement of precision medicine in Korea by conducting in-depth analysis of Korean genetic characteristics and enhancing disease prediction and diagnostic accuracy. ⠀ #Macrogen #NationalIntegratedBioBigDataProject #BioIndustry #BioBank #BioBigData #PrecisionMedicine #WGS #Genomics

We’re thrilled to announce the opening of the Macrogen Sejong Campus, our cutting-edge genome center designed to lead the future of #genomics. The Sejong Campus will be a 'Genome Foundry', powering large-scale genome production with advanced automation, and positioning itself as a central hub for genomic research and production. 🔬 This milestone marks an exciting new chapter for 마크로젠. By 2030, we are committed to evolving into a digital healthcare leader driven by AI and big data, further solidifying our position as a global leader in precision medicine and future healthcare. 🌐🧬 #genomics #newopening #digitalhealthcare #healthcare #sequencing #precisionmedicine

We are proud to announce that 마크로젠 has been awarded an 'A' ESG Rating by SUSTINVEST, a leading Korean ESG rating agency. ⠀ Macrogen scored over 28% higher than the industry average in the social category and achieved a perfect score in social contribution and community engagement. This reflects the strong recognition of our efforts in ESG management. ⠀ This achievement motivates us to integrate sustainable practices into our operations further, ensuring long-term value for our stakeholders and the environment. ⠀ Thank you to our dedicated team and partners for your continuous support in this journey. ⠀ #ESG #지속가능경영 #마크로젠 #Sustinvest #sustainability #macrogen

We are excited to announce that 마크로젠 has been selected as the first global member of Ultima Genomics’ Certified Service Provider program! 🎉 ⠀ Through a comprehensive evaluation process, Macrogen has been recognized for its excellence in delivering best-in-class #UG100™ sequencing services. ⠀ At Macrogen, we are dedicated to advancing global genomic research by offering cutting-edge solutions and leveraging our state-of-the-art genomic analysis infrastructure. ⠀ We look forward to empowering researchers around the globe and driving the future of genomics forward! 🌍🔬 #Genomics #sequencing #Macrogen #UltimaGenomics

마크로젠 웨비나에 초대합니다! Beyond the Genome:  Exploring the Service of Epigenomics and Proteomics ✨ 일시: 2024년 11월 29일(금) 오후 2시 #ATACsequencing 의 기본개념과 다양한 응용방법을 소개하고 #Olink 서비스의 단계별 과정과 결과 해석방법을 설명합니다. 전문가와 함께하는 마크로젠 웨비나! 미리 신청하시고 놓치지 마세요 😀 👇🏻👇🏻👇🏻👇🏻👇🏻 https://lnkd.in/gDknHDs2